抗HER2靶向治疗的耐药机制及治疗新策略

杨晓静, 徐 溢, 沈 赞

PDF(1657 KB)
《肿瘤》官方网站:www.tumorsci.org E-mail Alert
PDF(1657 KB)
肿瘤 ›› 2023, Vol. 43 ›› Issue (07) : 580-597. DOI: 10.3781/j.issn.1000-7431.2023.2210-0699
综述

抗HER2靶向治疗的耐药机制及治疗新策略

    {{javascript:window.custom_author_cn_index=0;}}
  • {{article.zuoZhe_CN}}
作者信息 +

Drug resistance mechanism and new treatment strategies of anti-HER2 targeted therapy

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

本文亮点

{{article.keyPoints_cn}}

HeighLight

{{article.keyPoints_en}}

摘要

{{article.zhaiyao_cn}}

Abstract

{{article.zhaiyao_en}}

关键词

Key words

本文二维码

引用本文

导出引用
{{article.zuoZheCn_L}}. {{article.title_cn}}. {{journal.qiKanMingCheng_CN}}. 2023, 43(07): 580-597. https://doi.org/10.3781/j.issn.1000-7431.2023.2210-0699
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 43(07): 580-597. https://doi.org/10.3781/j.issn.1000-7431.2023.2210-0699

参考文献

参考文献

{{article.reference}}

基金

版权

{{article.copyrightStatement_cn}}
{{article.copyrightLicense_cn}}
PDF(1657 KB)

Accesses

Citation

Detail

段落导航
相关文章

/